Company page

Nektar Therapeutics

Nektar Therapeutics is a public biotechnology company based in the United States, trading under the ticker NKTR. The company focuses on developing innovative therapies for various medical conditions. With a market capitalization of approximately $2.06 billion, Nektar is actively engaged in advancing its research and development efforts in the biopharmaceutical sector.